Table 1.
Demographics and baseline characteristics for opioid groups by quartiles.
Fig 1.
Proportions of overall (a) and stage-specific (b) recurrence in opioid usage groups by quartiles. Q1 (first quartile) = 819.0; Q2 (median) = 1359.6; Q3 (third quartile) = 2148.0.
Fig 2.
Proportions of overall (a) and stage-specific (b) death on opioid usage groups by quartiles. Q1 (first quartile) = 819.0; Q2 (median) = 1359.6; Q3 (third quartile) = 2148.0.
Table 2.
Parameters estimated in the multivariate logistic regression model.
Table 3.
Odds ratios of recurrence and death for 1 unit opioid usage increase over all cancer stage.
Fig 3.
Odds ratios of recurrence (a) and death (b) for 1 unit opioid usage increment over all the stages.
Fig 4.
Odds ratios of recurrence (a) and death (b) for all covariates. Others*: Large cell type, sarcomatoid type; CTx, Chemotherapy; VATS, Video-Assisted Thoracic Surgery.